The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Mr. Agather writes Jan. 23, “I hate to see stupidity rewarded.” As for me, I hate to see false and misleading claims rewarded. Hurricane-force winds and extraordinarily dry conditions were the prime ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Family members can receive up to $5,000 to cover services including childcare costs, clinical therapy or behavioral health ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

When the White House budget office released a memo this week that instructed all federal agencies to cease spending on any ...

Purdue’s Agricultural Economics Department covers a wide array of issues from development, trade, macroeconomics policy implications, agribusiness, production and consumption all the way to ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,01,355.31 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...